Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹36.82
Market cap: ₹35.57 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.6×Sector 47.4×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Financial Results 3 Board Meeting Date 3 Management Change 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 17:25 IST BSE

Financial Results

Sandu Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY

Sandu Pharmaceuticals Ltd reported revenue from operations of ₹16.4 Cr (-1.8% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · +0.0% YoY

Open full results → Read the filing ↗

5 May 2026 18:04 IST BSE

Financial Results

Sandu Pharmaceuticals Q4 FY26 Results: Net Profit ₹0 Cr

Sandu Pharmaceuticals Ltd reported revenue from operations of ₹16.9 Cr (+19.9% YoY) and net profit of ₹0 Cr for Q4 FY26.

Key figure: Net profit ₹0 Cr

Open full results → Read the filing ↗

5 May 2026 18:02 IST BSE

Financial Results

Sandu Pharmaceuticals Financial Results

Sandu Pharmaceuticals Ltd reported audited financial results for FY26 and recommended a final dividend of Rs. 1 per share (10%). The board also reappointed M/s Shekhar Joshi & Co as Cost Auditors and Akhil Pai & Co and Uday & Uday Associates as Internal Auditors for FY27.

Read the filing ↗